Company intelligence / Profile preview

PsycApps

London, England, United Kingdompsycapps.com ↗

Ownership: Private
Development stage: Commercial

Overview

PsycApps’ flagship product eQuoo is an evidence-based digital game clinically proven to enhance resilience, reduce anxiety, and lower depression in teens and young adults. Clinical trials have demonstrated robust engagement and positive outcomes. The platform is used by educational institutions as a scalable tool for student mental wellbeing[2][3][4][9].

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice (digital therapeutic/game-based intervention)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

eQuoo

Commercial

Indications: Anxiety, Depression, Mental health

Partnerships

Morningside Ventures (investor/partner)[2]NHS UK/National Health Service approval/distribution partner[2]Unilever distribution partner[2]

Beyond the preview

Go deeper on PsycApps.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PsycApps.

Explore the full profile